Advertisement

Topics

Search Results for "Paediatric Study Teriflunomide"

18:23 EST 17th November 2017 | BioPortfolio

Matching Channels

SERAPHIN study

SERAPHIN - STUDY WITH ENDOTHELIN RECEPTOR ANTAGONIST IN PULMONARY ARTERIAL HYPERTENSION TO IMPROVE CLINICAL OUTCOME. SERAPHIN (Study with an Endothelin Rece...

KIACTA

KIACTA™ (also known as eprodisate) is an orally bioavailable small molecule intended for the treatment of AA amyloidosis, an orphan indication that results from long-standing inflammatory cond...

Viruses

A virus is a small infectious agent that can replicate only inside the living cells of organisms. Virus particles (known as virions) consist of two or three parts: the genetic material made from eit...

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Matching News

Singulair Paediatric Drug Insights, 2017 [Report Updated: 10072017] Prices from USD $1000

DelveInsight's pharmaceuticals report, Singulair Paediatric Drug Insights, 2017 highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location....

Novartis plans filing for Gilenya in paediatric MS

Novartis is planning a filing for its Gilenya multiple sclerosis drug after a late-stage study showed it reduced multiple sclerosis relapses compared with standard care in children. The company's pae...

Singulair Paediatric API Insights, 2017 [Report Updated: 10072017] Prices from USD $500

DelveInsight's, Singulair Paediatric API Insights, 2017 report provides product and API manufacturers details across the globe along with the location. The report gives the clear idea on the country ...

Novartis celebrates success of Gilenya in paediatric multiple sclerosis

Novartis has announced results of its Phase 3 study investigating the safety and efficacy of Gilenya (fingolimod) , finding that the drug met its primary endpoint in the treatment of multiple sclerosi...

‘Not What We Expected,’ R&D Industry Says Of ‘Onerous’ EU Paediatric Regulation

The research-based drug industry has not minced its words in describing the problems it has faced from the EU Paediatric...    

New drug for paediatric nonverbal disorder developed

Biotechnology acceleration company, Q BioMed, has announced its successful development of a new and proprietary analogue of QBM-001 in partnership with Sphaera Pharma for paediatric nonverbal disorder...

touchNEUROLOGY Release: New Review Of The Emerging Role Of Teriflunomide In The Treatment Of Multiple Sclerosis

  Life Sciences Jobs   ...

Liquid biopsy spots aggressive paediatric brainstem cancer earlier without surgery

A particularly aggressive form of paediatric cancer can be spotted reliably by the genetic fragments it leaves behind in children's biofluids, opening the door to non-surgical biopsies and providing a...

Matching PubMed Articles

A case of lymphoma in a patient on teriflunomide treatment for relapsing multiple sclerosis.

Teriflunomide is an oral therapy approved for relapsing forms of multiple sclerosis which has been shown to reduce relapse rate and disability progression. We report the case of a 54-year -old black w...

The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies.

Teriflunomide is a once-daily oral immunomodulator approved for relapsing-remitting multiple sclerosis (MS). The objective of this post hoc analysis of the phase 3, pooled TEMSO (NCT00134563) and TOWE...

Teriflunomide restores 5-azacytidine sensitivity via activation of pyrimidine salvage in 5-azacytidine-resistant leukemia cells.

Previous studies showed that downregulation of pyrimidine salvage underlies resistance against 5-azacytidine (AZA), indicating an important role for de novo pyrimidine synthesis in AZA resistance. Bec...

Prospective Incidence of Paediatric Inflammatory Bowel Disease in New Zealand in 2015: Results from the PINZ Study.

The global incidence of paediatric inflammatory bowel disease (IBD) is increasing. Much of the evidence attesting to this has arisen from North America and Europe. There is a relative paucity of infor...

Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study.

Patient-reported outcomes (PROs) provide clinicians with further understanding of the impact of treatment on patients' daily lives. In addition, real-world studies, which employ broader inclusion crit...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement